How many institutions held OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share in Q1 2024?

109 institutional investors reported OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share for Q1 2024. Use the holders table for investor-level position and value details.

Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM)

Q: What does CUSIP 690145107 represent in this 13F holders report?

CUSIP 690145107 is the security identifier for OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690145107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 18,277,313
Total 13F shares: 50,439,872
Share change: -2,522,924
Total reported value: $111,971,022
Put/Call ratio: 51%
Price per share: $2.22
Number of holders: 109
Value change: -$20,061,860
Number of buys: 42
Number of sells: 74

Quarterly Holders Quick Answers

What is CUSIP 690145107?
CUSIP 690145107 identifies OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 690145107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	39%	7,066,782	$38,231,291	—	31 Dec 2023	13F
JPMORGAN CHASE & CO	13F	Company	27%	4,961,199	$26,840,086	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	22%	3,941,367	$21,322,796	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	21%	3,868,064	$20,926,229	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	21%	3,795,419	$20,533,218	—	31 Dec 2023	13F
T. Rowe Price Investment Management, Inc.	13F	Company	17%	3,166,747	$17,133,000	—	31 Dec 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	16%	2,982,490	$16,135,271	—	31 Dec 2023	13F
BRAIDWELL LP	13F	Company	13%	2,400,427	$12,986,310	—	31 Dec 2023	13F
Bellevue Group AG	13F	Company	9.6%	1,760,134	$9,522,325	—	31 Dec 2023	13F
Mubadala Investment Co PJSC	13F	Company	7.9%	1,440,601	$7,793,651	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	5.9%	1,076,757	$5,825,891	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	5.7%	1,038,800	$5,619,908	—	31 Dec 2023	13F
Assenagon Asset Management S.A.	13F	Company	5.6%	1,020,871	$5,522,912	—	31 Dec 2023	13F
C WorldWide Group Holding A/S	13F	Company	5.5%	1,000,000	$5,410,000	—	31 Dec 2023	13F
PFM Health Sciences, LP	13F	Company	5.5%	999,259	$5,405,991	—	31 Dec 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	4.6%	831,752	$4,499,778	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	4.5%	826,197	$4,469,723	—	31 Dec 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	4.4%	809,584	$4,379,849	—	31 Dec 2023	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	3.9%	707,558	$3,827,889	—	31 Dec 2023	13F
Fiera Capital Corp	13F	Company	3%	548,980	$2,969,982	—	31 Dec 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	2.8%	514,317	$2,782,000	—	31 Dec 2023	13F
NORGES BANK	13F	Company	2.5%	461,400	$2,496,174	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	2.4%	437,833	$2,368,677	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	2.3%	428,718	$2,319,365	—	31 Dec 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	2%	372,660	$2,016,091	—	31 Dec 2023	13F
Ensign Peak Advisors, Inc	13F	Company	2%	363,400	$1,965,994	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.9%	338,574	$1,831,685	—	31 Dec 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.8%	332,400	$1,798,000	—	31 Dec 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.7%	306,750	$1,659,518	—	31 Dec 2023	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	1.4%	257,143	$1,391,000	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.4%	247,415	$1,338,516	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.3%	237,807	$1,286,536	—	31 Dec 2023	13F
JANE STREET GROUP, LLC	13F	Company	1.2%	228,331	$1,235,270	—	31 Dec 2023	13F
Steven S. Williamson	3/4/5	Chief Commercial Officer	— class O/S missing	320,347	$1,143,639	—	15 Feb 2024	3/4/5
Susquehanna Portfolio Strategies, LLC	13F	Company	1.2%	211,119	$1,142,154	—	31 Dec 2023	13F
Qube Research & Technologies Ltd	13F	Company	1.1%	203,230	$1,099,474	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1%	186,608	$1,009,549	—	31 Dec 2023	13F
PDT Partners, LLC	13F	Company	0.94%	172,672	$934,156	—	31 Dec 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.91%	166,731	$902,015	—	31 Dec 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.91%	166,013	$896,000	—	31 Dec 2023	13F
FEDERATED HERMES, INC.	13F	Company	0.91%	165,597	$895,880	—	31 Dec 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.87%	158,849	$859,373	—	31 Dec 2023	13F
HRT FINANCIAL LP	13F	Company	0.83%	152,394	$824,000	—	31 Dec 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.82%	150,159	$812,360	—	31 Dec 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.77%	141,200	$763,892	—	31 Dec 2023	13F
Squarepoint Ops LLC	13F	Company	0.71%	129,765	$702,029	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.71%	129,156	$698,734	—	31 Dec 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	0.51%	92,634	$501,150	—	31 Dec 2023	13F
GRIFFIN ASSET MANAGEMENT, INC.	13F	Company	0.51%	92,614	$501,042	—	31 Dec 2023	13F
HighTower Advisors, LLC	13F	Company	0.46%	83,341	$449,000	—	31 Dec 2023	13F

Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) as of Q1 2024

As of 31 Mar 2024, Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,439,872 shares. The largest 10 holders included FMR LLC, AMERIPRISE FINANCIAL INC, MORGAN STANLEY, BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, BRAIDWELL LP, D. E. Shaw & Co., Inc., Ensign Peak Advisors, Inc, and Mubadala Investment Co PJSC. This page lists 109 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

137

Q1 2024 holders

109

Holder diff

-28

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.